The role of household contacts in the transmission of group A streptococci

Scandinavian Journal of Infectious Diseases

Volumn 29, Issue 3, 1997, Pages 239-244

  Falck, Göran ^a,d   Holm, Stig E ^b   Kjellander, Jan ^a   Norgren, Mari ^b   Schwan, Anna ^c  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^d Apoteksgardens Hlth Care Ctr   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G; PENICILLIN V;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM ISOLATION; CHILD; DISEASE TRANSMISSION; FAMILY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTHER; NOSE; PHARYNGITIS; RECURRENT INFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TONSILLITIS; TREATMENT FAILURE;

EID: 0347303647     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365549709019035     Document Type: Article

References (27)

1. Rammelkamp CH. Epidemiology of streptococcal infections. Harvey Lect 51: 113-142, 1956.
2. Wannamaker LW. The epidemiology of streptococcal infections. In: McCarty M, ed. Streptococcal Infections. New York: Columbia University Press, 1954, 157-175.
3. Hamburger M, Green MJ, Hamburger VG. The problem of the "dangerous carrier" of hemolytic streptococci. I. Number of hemolytic streptococci expelled by carriers with positive and negative nose cultures. J Infect Dis 77: 66-81, 1945.
4. Breese BB, Disney FA. Factors influencing the spread of beta-hemolytic streptococcal infections within the family group. Pediatrics 17: 834-838, 1956.
5. Dingle JH, Badger GF, Jordon WS. Illness in the home. Cleveland: Western Reserve University, 1964, 97-117.
6. Stillerman M, Bernstein SH. Streptococcal pharyngitis therapy. Am J Dis Child 107: 35-46, 1964.
7. Strömberg A, Schwan A, Cars O. Five versus ten days treatment of group A streptococcal pharyngotonsillitis: A randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil. Scand J Infect Dis 20: 37-46, 1988.
8. Rosenstein BJ, Markowitz M, Goldstein E, Kramer I, O'Mansky B, Seidel H, Sigler A, Tramer A. Factors involved in treatment failures following oral penicillin therapy of streptococcal pharyngitis. J Pediatr 73: 513-520, 1968.
9. Gastanaduy AS, Kaplan EL, Huwe BB, McKay C, Wannamaker LW. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet 2: 498-501, 1980.
10. Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. J Lab Clin Med 98: 326-335, 1981.
11. Griffith F. The serological classification of Streptococcus pyogenes. J Hyg 34: 542-584, 1934.
12. Maxted WR, Widdowson JP. The protein antigens of group A streptococci. In: Wannamaker LW, Matsen JM, eds. Streptococci and Streptococcal Diseases. New York/London: Academic Press, 1972, 256-261.
13. Norgren M, Norrby A, Holm SE. Genetic diversity in TIMI group A streptococci in relation to the clinical outcome of the infection. J Infect Dis 166: 1014-1020, 1992.
14. Chassy BM. A gentle method for the lysis of oral streptococci. 68: Biochem Biophys Res Commun. 68: 603-608, 1976.
15. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. New York: Cold Spring Habor Laboratory, 1989.
16. Levin RM, Grossman M, Jordan C, Ticknor W, Barnett P, Pascoe D. Group A streptococcal infection in children younger than three years of age. Pediatr Infect Dis 7: 581-587, 1988.
17. Kaplan EL. The group A streptococcal upper respiratory tract carrier state: An enigma. J Pediatr 97: 337-345, 1980.
18. Levine JI, Chapman SS, Guerra V, Cooper J, Krause RM. Studies on the transmission within families of group A hemolytic streptococci. J Lab Clin Med 67: 483-494, 1996.
19. Meyer RJ, Haggerty RJ. Streptococcal infection in families. Factors altering individual susceptibility. Pediatrics 29: 539-549, 1962.
20. Zimmerman RA, Wilson E. Familial susceptibility to acquisition of group A beta-hemolytic streptococci. Amer J Dis Child 116: 292-300, 1968.
21. Hansen JG, Schmidt H, Bitsch N, Sore throat. Principles of diagnosis and treatment. Practitioner 227: 937-948, 1983.
22. Schwartz RH, Wientzen RL, Pedreira F, Feroli EJ, Mclla GW, Guandolo VL. Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs ten therapy. JAMA 246: 1790-1795, 1981.
23. Cleary PP, Kaplan EL, Livdahl C, Skjold S. DNA fingerprints of Streptococcus pyogenes are M type specific. J Infect Dis 158: 1317-1328, 1988.
24. Holm SE, Roos K, Strömberg A. A randomized study of treatment of streptococcal pharynotonsillitis with cefadroxil or phenoxymetylpenicillin (penicillin V). Pediatr Infect Dis J 10: S68-S71, 1991.
25. Sanders CC, Sanders WE, Harrowe DJ. Bacterial interference: Effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci. Infect Immun 13: 808-812, 1916.
26. Roos K, Grahn E, Holm SE. Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand J Infect Dis 18: 313-319, 1986.
27. Grahn E, Holm SE. Penicillin concentration in saliva and its influence on bacterial interference. Scand J Infect Dis 19: 235-241, 1987.